These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1328979)
1. A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. Muchtar S; Almog S; Torracca MT; Saettone MF; Benita S Ophthalmic Res; 1992; 24(3):142-9. PubMed ID: 1328979 [TBL] [Abstract][Full Text] [Related]
2. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits. Naveh N; Muchtar S; Benita S J Ocul Pharmacol; 1994; 10(3):509-20. PubMed ID: 7836859 [TBL] [Abstract][Full Text] [Related]
3. A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits. Naveh N; Weissman C; Muchtar S; Benita S; Mechoulam R Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):334-8. PubMed ID: 10853933 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits. Puras G; Santafé J; Segarra J; Garrido M; Melena J Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1559-67. PubMed ID: 17505840 [TBL] [Abstract][Full Text] [Related]
5. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension]. Xu Y; Chen Z; Song J Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220 [TBL] [Abstract][Full Text] [Related]
6. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S Drug Deliv Transl Res; 2021 Oct; 11(5):2096-2107. PubMed ID: 33169348 [TBL] [Abstract][Full Text] [Related]
7. The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with alpha-chymotrypsin-induced ocular hypertension. Puras G; Santafé J; Segarra J; Garrido M; Melena J Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):322-8. PubMed ID: 11981648 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle. Klang SH; Frucht-Pery J; Hoffman A; Benita S J Pharm Pharmacol; 1994 Dec; 46(12):986-93. PubMed ID: 7714723 [TBL] [Abstract][Full Text] [Related]
9. Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits. Privitera MG; Potenza M; Bucolo C; Leggio GM; Drago F J Ocul Pharmacol Ther; 2007 Jun; 23(3):232-9. PubMed ID: 17593006 [TBL] [Abstract][Full Text] [Related]
10. Interaction between delta-9-tetrahydrocannabinol and indomethacin. Green K; Kearse EC; McIntyre OL Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074 [TBL] [Abstract][Full Text] [Related]
11. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability. Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267 [TBL] [Abstract][Full Text] [Related]
12. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits. Stein PJ; Clack JW Invest Ophthalmol Vis Sci; 1994 May; 35(6):2765-8. PubMed ID: 8188470 [TBL] [Abstract][Full Text] [Related]
13. The effect of topical dihydroergocristine on the intraocular pressure in alpha-chymotrypsin-induced ocular hypertensive rabbits. Melena J; Santafé J; Segarra J Methods Find Exp Clin Pharmacol; 1998 Dec; 20(10):861-7. PubMed ID: 10091223 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS J Ocul Pharmacol Ther; 2012 Oct; 28(5):515-23. PubMed ID: 22671995 [TBL] [Abstract][Full Text] [Related]
15. Prevention of topical and ocular oxidative stress by positively charged submicron emulsion. Benita S Biomed Pharmacother; 1999 May; 53(4):193-206. PubMed ID: 10392291 [TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure, ocular toxicity and neurotoxicity in response to 11-hydroxy-delta 9-tetrahydrocannabinol and 1-nantradol. Colasanti BK J Ocul Pharmacol; 1985; 1(2):123-35. PubMed ID: 2851633 [TBL] [Abstract][Full Text] [Related]
17. Impact of mucoadhesive agent inclusion on the intraocular pressure lowering profile of Δ Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S Int J Pharm; 2022 Mar; 616():121564. PubMed ID: 35151817 [TBL] [Abstract][Full Text] [Related]
18. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man. Green K; Roth M Arch Ophthalmol; 1982 Feb; 100(2):265-7. PubMed ID: 6279061 [TBL] [Abstract][Full Text] [Related]
19. Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins. Hippalgaonkar K; Gul W; ElSohly MA; Repka MA; Majumdar S AAPS PharmSciTech; 2011 Jun; 12(2):723-31. PubMed ID: 21637944 [TBL] [Abstract][Full Text] [Related]
20. The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat. Innemee HC; Hermans AJ; van Zwieten PA Doc Ophthalmol; 1980 Apr; 48(2):235-41. PubMed ID: 6249559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]